Brain Cannabinoid Systems as Targets for the Therapy of Neurological Disorders
- 31 December 1998
- journal article
- clinical trial
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 5 (6), 534-551
- https://doi.org/10.1006/nbdi.1998.0220
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Complex pharmacology of natural cannabivoids: Evidence for partial agonist activity of Δ9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptorsLife Sciences, 1998
- AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brainLife Sciences, 1997
- Nitric oxide neurotoxicityJournal of Chemical Neuroanatomy, 1996
- AM630, a competitive cannabinoid receptor antagonistLife Sciences, 1995
- The design, synthesis and testing of desoxy-CBD: Further evidence for a region of steric interference at the cannabinoid receptorLife Sciences, 1995
- An examination of the central sites of action of cannabinoid-induced antinociception in the ratLife Sciences, 1995
- A simple model of the interactions of dopamine, acetylcholine and GABA in movement disorders seen in psychiatryMedical Hypotheses, 1988
- Treatment of Human Spasticity with Δ9‐TetrahydrocannabinolThe Journal of Clinical Pharmacology, 1981
- Marihuana as a therapeutic agent for muscle spasm or spasticityPsychosomatics, 1980
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964